tldrdailynews.com logo

FDA Approves Moderna's Next-Generation COVID-19 Vaccine for Adults 65+

1 min read
Source: Axios
FDA Approves Moderna's Next-Generation COVID-19 Vaccine for Adults 65+
Photo: Axios
TL;DR

The FDA has approved Moderna's new COVID-19 vaccine, mNEXSPIKE, for adults 65+ and those 12-64 with underlying conditions, marking the first approval under stricter standards requiring more studies, and signaling a shift in vaccine recommendations for healthy children and pregnant women.

Topics:top-newshealth#approval#covid-19-vaccine#fda#health#moderna#public-health
Share this article
  1. FDA approves new Moderna COVID-19 vaccine  Axios
  2. US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older  Reuters
  3. FDA approves a next-generation Covid vaccine from Moderna, with restrictions  statnews.com
  4. Moderna Wins Narrower US Approval for New Covid Vaccine  Bloomberg
  5. Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE  USA Today

Want the full story? Read the original reporting

Read on Axios